A syndrome associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses, marked by the presence of antibodies directed against phospholipids.
Definition (MSH)
The presence of antibodies directed against phospholipids (ANTIBODIES, ANTIPHOSPHOLIPID). The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies (ANTIBODIES, ANTICARDIOLIPIN). Present also are high levels of lupus anticoagulant (LUPUS COAGULATION INHIBITOR).
Definition (CSP)
associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses; involves the presence of antibodies directed against phospholipids; cardiolipins show markedly elevated levels of anticardiolipin antibodies; present also are high levels of lupus anticoagulant; in pregnancy it can cause abortion.
Síndrome antifosfolipídica, Síndrome Antifosfolípide, Síndrome Antifosfolipídica, Síndrome do Anticorpo Antifosfolípide, Síndrome dos Anticorpos Antifosfolípides
French
Syndrome des anti-phospholipides, Syndrome de Soulier, Syndrome des anticorps antiphospholipides (SAPL), Syndrome des anticorps antiphospholipides, Syndrome des antiphospholipides